Skip Navigation


Brain Advance Access originally published online on September 1, 2004
Brain 2004 127(10):2183-2192; doi:10.1093/brain/awh258
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
127/10/2183    most recent
awh258v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (28)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Beretta, S.
Right arrow Articles by Ferrarese, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Beretta, S.
Right arrow Articles by Ferrarese, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Brain Vol. 127 No. 10 © Guarantors of Brain 2004; all rights reserved

Leber hereditary optic neuropathy mtDNA mutations disrupt glutamate transport in cybrid cell lines

Simone Beretta1, Laura Mattavelli1,2, Gessica Sala1, Lucio Tremolizzo1,2, Anthony H.V. Schapira5,6, Andrea Martinuzzi3, Valerio Carelli4 and Carlo Ferrarese1,2,3

1 Department of Neuroscience and Biomedical Technologies, University of Milano-Bicocca, Monza, 2 Department of Neurology, San Gerardo Hospital, Monza, 3 Scientific Institute Eugenio Medea, Conegliano and Bosisio Parini Research Centres, 4 Department of Neurological Sciences, University of Bologna, Bologna, Italy, 5 University Department of Clinical Neurosciences, Royal Free and University College Medical School, and 6 Institute of Neurology, University College London, London, UK

Correspondence to: Professor Carlo Ferrarese, Department of Neurology, University of Milano-Bicocca, San Gerardo Hospital, via Donizetti, 106 – 20052 Monza (MI), Italy E-mail: carlo.ferrarese{at}unimib.it

Leber hereditary optic neuropathy (LHON) is a maternally inherited form of retinal ganglion cell degeneration leading to optic atrophy which is caused by point mutations in the mitochondrial genome (mtDNA). Three pathogenic mutations (positions 11778/ND4, 3460/ND1 and 14484/ND6) account for the majority of LHON cases and they affect genes that encode for different subunits of mitochondrial complex I. Excitotoxic injury to retinal ganglion cells and the optic nerve has been previously hypothesized, especially given the high susceptibility of this neural cell type to glutamate toxicity. Osteosarcoma-derived cytoplasmic hybrids (cybrids) generated from six unrelated LHON patients, two cell lines for each pathogenic mutation, were compared with cybrids obtained from three healthy controls. Molecular and biochemical analyses showed that excitatory amino acid transporter 1 (EAAT1)/GLAST is the most active glutamate transporter in this cellular model. The glutamate uptake maximal velocity was significantly reduced in all LHON cybrids compared with control cybrids. This reduction was correlated in a mutation-specific fashion with the degree of mitochondrial production of reactive oxygen species, which is enhanced in LHON cybrids. Our findings support the hypothesis that the genetically determined mitochondrial dysfunction in LHON patients leads to impaired activity of the EAAT1 glutamate transporter. This observation is particularly relevant since EAAT1 is the major means of glutamate removal in the inner retina and this prevents retinal ganglion cells being damaged as a result of excitotoxicity.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Med. Genet.Home page
P Yu-Wai-Man, P G Griffiths, G Hudson, and P F Chinnery
Inherited mitochondrial optic neuropathies
J. Med. Genet., March 1, 2009; 46(3): 145 - 158.
[Abstract] [Full Text] [PDF]

Home page
 Hum Mol GenetHome page
R. Pello, M. A. Martin, V. Carelli, L. G. Nijtmans, A. Achilli, M. Pala, A. Torroni, A. Gomez-Duran, E. Ruiz-Pesini, A. Martinuzzi, et al.
Mitochondrial DNA background modulates the assembly kinetics of OXPHOS complexes in a cellular model of mitochondrial disease
Hum. Mol. Genet., December 15, 2008; 17(24): 4001 - 4011.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
D. F. Ventura, M. Gualtieri, A. G. F. Oliveira, M. F. Costa, P. Quiros, F. Sadun, A. M. de Negri, S. R. Salomao, A. Berezovsky, J. Sherman, et al.
Male Prevalence of Acquired Color Vision Defects in Asymptomatic Carriers of Leber's Hereditary Optic Neuropathy
Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2362 - 2370.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
X. Qi, L. Sun, W. W. Hauswirth, A. S. Lewin, and J. Guy
Use of Mitochondrial Antioxidant Defenses for Rescue of Cells With a Leber Hereditary Optic Neuropathy-Causing Mutation
Arch Ophthalmol, February 1, 2007; 125(2): 268 - 272.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
D. F. Ventura, P. Quiros, V. Carelli, S. R. Salomao, M. Gualtieri, A. G. F. Oliveira, M. F. Costa, A. Berezovsky, F. Sadun, A. M. de Negri, et al.
Chromatic and Luminance Contrast Sensitivities in Asymptomatic Carriers from a Large Brazilian Pedigree of 11778 Leber Hereditary Optic Neuropathy
Invest. Ophthalmol. Vis. Sci., December 1, 2005; 46(12): 4809 - 4814.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.